yeah, no surprises there. A solid result, sales trajectory continues to improve, and the expansion in the sales force is delivering the results expected and costs are being managed well.
There is certainly more focus on R&D which suggests they are confident the business is getting to a stage where sales are less lumpy and getting more predictable which is what you’d expect.
Ann: FY22 Results Presentation, page-15
-
- There are more pages in this discussion • 481 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.36 |
Change
0.020(0.85%) |
Mkt cap ! $1.628B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.40 | $2.33 | $1.160M | 491.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5181 | $2.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.36 | 1873 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |